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INTRODUCTION
Depression, one of the most common diseases in older 
adults, is a significant cause of morbidity and mortality.1,2 As 
the population ages in high-income countries, depression is 
projected to become the greatest contributor to illness burden 
by the year 2030.3 Moreover, because elderly persons with 
depression often do not receive diagnosis and treatment,4 and 
current treatments achieve remission in only approximately 
30-35% of older adults,5 more than two-thirds of the disease 
burden remains,6,7 leading to staggering healthcare costs.8 
Hence, efforts to identify risk factors that facilitate diag-
nosis and permit the development of targeted interventions to 
prevent depression are needed.9-11
In the elderly population, female sex, bereavement, prior 
depression, disability, and sleep disturbance are significant 
risk factors for depression.11,12 Among modifiable risk factors, 
increasing attention has focused on sleep disturbance. Whereas 
longitudinal studies have found that mental health problems, 
especially depression, predict incident insomnia13 and its 
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persistence,14,15 sleep disturbance also predicts depression. For 
example, in the general population, a recent meta-analysis of 
longitudinal epidemiologic studies reports that symptoms of 
insomnia predict depression (odds ratio [OR] = 2.6, confidence 
interval [CI] = 1.98-3.42), although the results were heteroge-
neous.16 Importantly, findings in older adults are limited, with 
only eight existing studies identified, which include clinical and 
primary care populations.11,17-23 Four of these studies describe 
the prospective effect of sleep disturbance on depression risk 
in community-dwelling older adults.11,17,21,23 Two studies that 
considered the role of depression history11,17 found that the asso-
ciation between sleep disturbance and depression recurrence is 
substantially greater than with its occurrence.11,17
Sleep disturbance in depressed patients often lingers and 
its persistence can represent a residual phase of a major mood 
disorder. Conversely, the emergence of disturbed sleep may 
be a precursor or prodrome of depression that occurs later in 
life.24 Regardless of the temporal relationship between sleep 
disturbance and depressive episodes, few studies have evalu-
ated the contribution of the persistence and severity of sleep 
disturbance to depression risk. Most prior studies assessed 
sleep disturbance at a single time point (i.e., baseline) with a 
single follow-up assessment of depression.11,16,23 Nevertheless, 
some evidence suggests that persistent insomnia co-occurs 
with depression in adults24-26 and in older adults in primary care 
settings,22,27 and is associated with depression nonremission.28 
Yet, these studies concurrently assessed sleep disturbance and 
depression without consideration of their temporal overlap and 
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it is not known whether persistent sleep disturbance plays an 
independent role in depression risk in older adults. Further-
more, most of the aforementioned studies have relied solely 
on patient-reported symptoms of depressive symptoms, and 
have not assessed the presence of depression using diagnostic 
criteria.
In this 2-year longitudinal study of community-dwelling 
older adults, we tested two hypotheses: (1) depression at 
year 2 will be higher among older adults with persistent sleep 
disturbance during year 1 (i.e., between the baseline and 
year 1 assessments) than those without sleep disturbance, 
and (2) among older adults who were not depressed at year 1, 
occurrence of depression during year 2 will be higher among 
those with persistent sleep disturbance during year 1 than 
those without sleep disturbance. To test these hypotheses, we 
performed repeated assessments using the Structured Clinical 
Interview for DSM-IV (SCID) for depression and the Pittsburgh 
Sleep Quality Index (PSQI) for sleep disturbance in a sample 
of community-dwelling older adults who had prior depression, 
current depression, or no history of mental illness.
METHODS
Patients and Procedure
This article extends the findings of the Depression Substudy 
of the Department of Veterans Affairs Cooperative Study #403, 
Shingles Prevention Study,29 and Cho et al.17 by evaluating 
the effect of persistence and severity of sleep disturbance on 
depression at year 2 in community-dwelling older adults. The 
institutional review boards of the University of Colorado at 
Denver, University of California at San Diego, and University 
of California at Los Angeles approved all procedures.
The Depression Substudy screened 2,858 participants age 
60 years or older from three urban areas (Los Angeles, Denver, 
and San Diego) to identify persons who screened negative for 
a depression history (n = 211) and those who screened positive 
for a depression history (i.e., either a current or past history 
of depression; n = 22017; Figure 1). Immediately following 
screening, screened eligible individuals underwent baseline 
assessment with administration of the SCID-IV and a systematic 
medical history interview. Inclusion, exclusion, and matching 
criteria have been described previously.17,30,31
Assessment methods included administration of the SCID-IV 
with characterization of the current and/or most recent three 
depression episodes (e.g., major or nonmajor classification, medi-
cation used, date of onset) as previously described.17,30,31 Among 
those who screened eligible as having no history of a depression 
episode (n = 211), the more rigorous assessment methods of the 
SCID identified four participants with substance-related depres-
sive disorder and these individuals were excluded. The medical 
history interview identified one participant with sleep disordered 
breathing and this individual was excluded. Among those who 
screened eligible as having a current or past history of depres-
sion (n = 220), SCID and medical history interviews excluded 
four participants with substance-related depressive disorder and 
three participants with sleep disordered breathing. The final 
sample was composed of the following groups based on SCID 
interview data: 145 individuals with prior history of depression; 
68 with current depression; and 206 control individuals who 
were never mentally ill (Figure 1).
Figure 1—Consolidated Standards of Reporting Trials flow diagram of subject entry and evaluation.
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All participants were assessed at baseline, 6 weeks later, 
1 year later, and 2 years later as previously reported17,30,31; 
follow-up rates at 6 weeks, year 1, and year 2 were 98.8% 
(n = 414), 93.8% (n = 393), and 91.2% (n = 382), respectively. 
Figure 1 shows the rates of year 2 follow-up for each group. 
Follow-up assessments included evaluation of depression 
with SCID interview with identification of date (± 1 month) 
of remission or recurrence. Depression severity was assessed 
with the 24-item Hamilton Depression Rating Scale (HAMD).32 
To eliminate overlap between the HAMD and PSQI, scores for 
three sleep disturbance-related items (questions 11, 12, and 13) 
were subtracted from the total HAMD score. The PSQI was 
used to assess the severity of sleep disturbance. The PSQI 
consists of 19 self-rated items that measure subjective sleep 
quality, sleep latency, and use of sleep medication during the 
past month. A PSQI global score > 5 has a sensitivity of 98.7% 
and a specificity of 84.4% as a marker for sleep disturbance.33,34 
We also evaluated chronic medical burden with the Chronic 
Disease Score (CDS), a standardized measure based on self-
reported prescription medication use.35
Statistical Analysis
Analyses of the data were conducted using SPSS version 
18 for Windows (IBM, New York, NY). Group differences 
in participant characteristics at baseline were compared using 
analysis of variance. For categorical variables, Pearson chi-
square tests were used.
The primary outcome variable was the presence of DSM-IV-
diagnosed depression at year 2. Logistic regression was used to 
evaluate the effects of sleep disturbance and its persistence on 
depression at year 2. Sleep disturbance (PSQI > 5) during the 
interval from baseline to year 1 was classified as persistent if 
it was present at all three assessments (i.e., baseline, 6 weeks, 
and 1 year), intermittent if present at one or two assessments, 
and absent if not identified at any assessment. As all indepen-
dent variables were a priori potential risk factors for depression 
at year 2 (baseline depression status [prior depression, current 
depression, or control], antidepressant and sedative-hypnotic 
medication use, depressive symptoms [HAMD], and chronic 
medical burden [CDS]), or sociodemographic characteristics 
(age, sex, marital status, and education), they were included into 
the multivariable model. Because the overwhelming majority 
of the sample was Euro-American (96.7%), ethnicity was not 
included in analyses. We also assessed the potential effect 
modification by baseline depression status on the prospective 
association between persistent sleep disturbance and depression 
at year 2.
Among the patients identified with depression at year 2, a 
subgroup was not depressed at year 1 but rather newly devel-
oped depression during the interval between year 1 and year 2. 
Such newly developed cases of depression were actually recur-
rent depression during that interval because no one in the control 
group developed depression. To examine the association of 
persistent sleep disturbance and newly developed depression at 
year 2, a survival analysis was performed. Using a Cox regres-
sion model including participants who were not depressed at 
year 1, depression-free survival was calculated from the date of 
the year 1 assessment to date of depression onset during year 2 
(or at year 2 for censored cases), with adjustment using the same 
set of covariates described previously. The date of depression 
onset was based on follow-up SCID data. Sleep disturbance 
was categorized into three categories: persistent, intermittent, 
or absent.
To examine the association of sleep disturbance severity at 
baseline (i.e., PSQI total score) with depression at year 2, a 
logistic regression model was performed, using the same set of 
covariates described previously. Secondary analyses explored 
whether the effect of sleep disturbance severity on depression at 
year 2 remained after persistent sleep disturbance was entered 
into the model.
RESULTS
Demographic and Clinical Characteristics
Table 1 describes the characteristics of study participants 
at the baseline assessment. The control group was older and 
more likely to be married than the two depression groups, 
and the prior depression group was more educated than the 
control group and the current depression group. Sex, ethnicity, 
and chronic medical burden (i.e., CDS) did not differ among 
groups. Clinical variables related to the severity of depres-
sive symptoms and sleep disturbance differed significantly 
among groups, with the current depression group having 
more severe depressive symptoms, worse sleep quality, and a 
greater proportion of patients with clinical sleep impairment 
(i.e., PSQI scores > 5) than the control or prior depression 
groups. Although the prior depression group had more severe 
depressive symptoms than the control group, the severity was 
quite low (i.e., mean HAMD of 2.0, which is considered “no 
or minimal symptoms”). The level of sleep disturbance in the 
depression groups was higher than that in the control group, 
with 46% of those with prior depression and 79% of those with 
current depression classified as having clinical sleep distur-
bance, compared with only 18% of control patients. Consid-
ering the depression groups, the number of major depressive 
episodes and rate of antidepressant and/or sleep medication 
use were significantly higher in the current depression group 
compared with the prior depression group. In the prior depres-
sion group, the median time since the last depressive episode 
was almost 10 years (118 months), indicative of a sustained 
period of remission.
At the year 2 follow-up, a depressive disorder was diagnosed 
in 33 participants, with 12 cases from the prior depression 
group and 21 cases from the current depression group including 
17 cases who were persistently depressed throughout the 2-year 
period (Figure 1). The diagnosis of depression at year 2 was not 
made in any of the control patients, although depression was 
diagnosed in one individual at year 1, but this person was lost 
to follow-up at year 2. Hence, analyses of the prospective asso-
ciation of persistence of sleep disturbance with the presence of 
depression at year 2 were limited to patients in the prior and 
current depression groups (n = 213).
Predictors of Depression at Year 2
In prior analyses of this dataset, we demonstrated that the 
presence of sleep disturbance (PSQI > 5) at baseline is a risk 
factor for the recurrence of depression over a 2-year follow-
up period among patients with a history of depression.17 Here, 
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we examine the contribution of sleep disturbance severity 
and persistence during year 1 on depression at year 2. Across 
the three assessments that occurred during year 1, a total of 
72 participants in the two depression groups were found to have 
persistent sleep disturbance; 30% of those with prior depression 
and 41% in the current depression group were categorized as 
having persistent sleep disturbance (Table 1). Intermittent sleep 
disturbance was observed for 84 participants; 37% of those 
with prior depression and 46% of those in the current depres-
sion group. The absence of sleep disturbance was observed for 
57 participants; 33% of those with prior depression and 13% of 
those in the current depression group.
The presence of sleep disturbance varied across each of the 
assessments for each of the groups (Figure S1). For example, 
in the prior depression group, sleep disturbance at baseline had 
remitted in 18% at 6 weeks, and sleep disturbance at 6 weeks 
had remitted in 18% at year 1. Conversely, among those in the 
prior depression group without sleep disturbance at baseline, 
22% had the onset of sleep disturbance at 6 weeks and 24% had 
the onset of sleep disturbance at year 1. In the current depres-
sion group, sleep disturbance present at baseline had remitted in 
22% at 6 weeks, and sleep disturbance at 6 weeks had remitted 
in 13% at year 1. Conversely, among those in the current depres-
sion group without sleep disturbance at baseline, 36% had the 
onset of sleep disturbance at 6 weeks and 35% had the onset of 
sleep disturbance at year 1.
Using logistic regression analysis, we found that persis-
tent sleep disturbance during year 1 was a robust predictor of 
depression at year 2, even after adjusting for baseline depres-
sion status, antidepressant and hypnotic-sedative medication 
use, severity of depressive symptoms, chronic medical burden, 
and sociodemographic variables including age, sex, marital 
status, and years of education (adjusted OR = 5.20, CI = 1.16 to 
Table 1—Baseline participant characteristics
Variable
Prior depression 
(n = 145) 
Current depression 
(n = 68)
Control 
(n = 206) P
Age (60 to 95 years)a, mean (SD), years 67.8 (6.4) 67.7 (5.7) 70.0 (6.3) 0.001
Sex, female, No. (%) 86 (58.3) 41 (60.3) 105 (51.0) 0.20
Marital status, married,a No. (%) 81 (55.9) 36 (52.9) 139 (67.5) 0.03
Ethnicity, Euro-American, No. (%) 143 (98.6) 63 (92.6) 199 (96.6) 0.08
Education (10 to 18 years),b mean (SD) 16.0 (2.2) 14.8 (2.3) 15.3 (2.3) 0.001
Chronic disease score (0 to 11), mean (SD) 2.3 (2.2) 1.8 (1.8) 1.9 (2.2) 0.17
HAMD (0 to 27, minus sleep items)c, mean (SD) 2.0 (2.8) 9.4 (6.9) 0.8 (1.4) < 0.001
PSQI (0 to 18)c, mean (SD) 5.9 (3.7) 8.8 (3.9) 3.6 (2.8) < 0.001
Sleep disturbance (PSQI > 5),c No. (%) 66 (45.5) 54 (79.4) 36 (17.5) < 0.001
Persistent sleep disturbance,c No. (%) 44 (30.3) 28 (41.2) 16 (7.8) < 0.001
Intermittent sleep disturbance,c No. (%) 53 (36.6) 31 (45.6) 51 (24.8) < 0.001
No. of major depressive episodes (0 to 9),c mean (SD) 1.1 (0.9) 1.6 (1.4) 0 (0) < 0.001
Antidepressant medication use,c No. (%) 47 (32.4) 32 (47.1) 0 (0) < 0.001
Sedative-hypnotic medication use,a No. (%) 53 (36.6) 28 (41.2) 39 (18.9) < 0.001
Depression at year 2c, No. (%) 12 (9.2) 21 (39.6) 0 (0) < 0.001
All data except depression at year 2 were obtained from the baseline assessment. aIndicates significantly different from control group. bIndicates significantly 
different from prior depression group. cIndicates significantly different from each other group. HAMD, Hamilton Depression Rating Scale; PSQI, Pittsburgh 
Sleep Quality Index; SD, standard deviation.
Table 2—Associations of persistent sleep disturbance during year 1 with 
presence of depression at year 2a,b
Odds ratio (95% CI) P 
Unadjusted
Intermittent 4.29 (0.48-38.15) 0.19
Persistent 8.40 (0.99-71.59) 0.05
Model 1 adjusted for sociodemographic variablesb
Intermittent 3.06 (0.77-12.16) 0.11
Persistent 5.52 (1.46-20.91) 0.01
Model 2, adjusted for model 1+chronic medical burden
Intermittent 3.09 (0.78-12.29) 0.12
Persistent 5.73 (1.50-21.91) 0.01
Model 3, adjusted for model 2+depressive symptoms
Intermittent 2.74 (0.68-11.02) 0.16
Persistent 4.62 (1.17-18.30) 0.03
Model 4, adjusted for model 3+antidepressant and sedative-
hypnotic use
Intermittent 2.96 (0.69-12.62) 0.14
Persistent 4.86 (1.13-20.9) 0.03
Model 5, adjusted for model 4+baseline depression status
Intermittent 2.55 (0.56-11.51) 0.23
Persistent 5.20 (1.16-23.29) 0.03
aPrior depression includes those who entered the study with a history 
of depression or current depression, not including control participants. 
bReference is absent sleep disturbance group (n = 57). cSociodemographic 
variables include age, sex, marital status, and education. Chronic medical 
burden includes chronic disease score. Depression symptoms were 
measured by Hamilton Depression Rating Scale (minus sleep items).
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had a recurrence of depression during year 2, including nine in 
the prior depression group and four who had been depressed 
at baseline but had remitted at year 1. To determine whether 
persistent sleep disturbance was prospectively associated with 
depression recurrence during year 2, a survival analysis was 
performed. As shown in Figure 2, persistent sleep disturbance 
during year 1 was a significant predictor of depression recur-
rence during year 2 after controlling for the socio-demographic 
and clinical variables, including baseline depression status, listed 
previously (adjusted hazards ratio = 16.05, CI = 1.21 to 213.06, 
P = 0.035). Intermittent sleep disturbance was not significantly 
associated with depression recurrence during year 2 (adjusted 
hazard ratio = 5.61, CI = 0.47 to 66.96, P = 0.17). Severity of 
depressive symptoms (with sleep items deleted), antidepressant 
use, low level of education, unmarried status, and younger age 
were also significant predictors of depression recurrence during 
year 2 (Table 3).
DISCUSSION
The results of this 2-year longitudinal study of community-
dwelling older adults confirmed our hypotheses. Among older 
adults with a history of depression or current depression, sleep 
disturbance that persisted for 1 year predicted depression 
during the following year. Furthermore, among older adults 
who were not depressed at the year 1 assessment, persistent 
sleep disturbance predicted depression recurrence during year 
2. Importantly, the prospective association of persistent sleep 
disturbance with depression persistence and recurrence was 
23.29, P = 0.03; Table 2). This effect was not modified by base-
line depression status (i.e., current versus prior depression; 
P = 0.81). Intermittent sleep disturbance was not significantly 
associated with depression at year 2 (adjusted OR = 2.55, 
CI = 0.56 to 11.51, P = 0.23; Table 2). In addition, when sleep 
disturbance was identified only at the year 1 assessment but 
not persistent throughout the year, this recent sleep disturbance 
was also not predictive of depression at year 2 (unadjusted 
OR = 3.88, CI = 0.77 to 19.66, P = 0.10). Finally, although 
we had excluded four patients who reported sleep disordered 
breathing, an additional seven participants endorsed items 5d 
and 5e of the PSQI (item scores > 3), which suggested the pres-
ence of symptoms of sleep apnea; exclusion of these additional 
seven participants did not alter the results.
Most participants (58%) with depression at year 2 had 
persistent sleep disturbance during year 1. Only 33% and 9% of 
participants with depression at year 2 reported intermittent and 
absent sleep disturbance, respectively, during year 1 (χ2 = 9.30, 
P = 0.01).
Additional analyses were performed to test whether severity 
of sleep disturbance predicted depression at year 2. Using 
logistic regression analyses, we found no association between 
severity of sleep disturbance and depression at year 2 (adjusted 
OR = 1.12, CI = 0.98 to 1.23, P = 0.11). Further adjustment for 
the presence of persistent sleep disturbance did not alter this 
nonsignificant result (OR = 1.02, CI = 0.85 to 1.21, P = 0.85).
Predictors of Depression Recurrence at Year 2
Of the 33 participants with depression at year 2, 13 experienced 
a recurrence of depression between year 1 and year 2 (Figure 1). 
In other words, these participants were not depressed at year 1 but 
Table 3—Predictors of depression recurrence during year 2
Predictors
Adjusted hazard 
ratioa,b (95% CI) P 
Persistent sleep disturbance 16.05 (1.21-213.06) 0.04
Intermittent sleep disturbance 5.61 (0.47-66.96) 0.17
Agec 0.84 (0.74-0.96) 0.01
Sex 0.70 (0.19-2.60) 0.59
Marital statusd 12.24 (1.83-82.08) 0.01
Educatione 0.55 (0.38-0.79) 0.001
Chronic medical burden 1.00 (0.70-1.44) 0.99
Depressive symptomsf 0.81 (0.67-0.97) 0.02
Use of antidepressant medicationsg 5.01 (1.39-18.07) 0.01
Use of sedative-hypnotic medications 1.32 (0.28-6.15) 0.72
Depression group statush 6.74 (0.80-56.83) 0.08
aAdjusted for all other variables in the table. bReference is the absence of 
sleep disturbance group (n = 57). cYounger age is more likely associated 
with depression recurrence than older age. dNot married is more likely 
associated with depression recurrence than married. eFewer years of 
education is more likely associated with depression recurrence than more 
years of education. fGreater depressive symptoms is more likely associated 
with depression recurrence than less depressive symptoms. gUse of 
antidepressants medications is more likely associated with depression 
recurrence than nonuse of such medications. hCurrent depression at 
baseline is more likely associated with depression recurrence than prior 
depression history. All variables except chronic and intermittent sleep 
disturbance were measurements at baseline. Chronic medical burden 
was evaluated by Chronic Disease Score. Depressive symptoms were 
measured by Hamilton Depression Rating Scale (minus sleep items).
Figure 2—Time to onset of depression recurrence during year 2 stratified 
by sleep disturbance during year 1.
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independent of baseline depression status, other depressive 
symptoms, sociodemographic characteristics, chronic medical 
burden, and antidepressant and sedative-hypnotic use. Neither 
intermittent sleep disturbance nor its severity was associated 
with depression or its recurrence at year 2. However, this study 
may not have been adequately powered to evaluate the role 
of intermittent sleep disturbance; studies using larger sample 
sizes and longer follow-up periods may be required. Neverthe-
less, these findings are unique in showing that persistent sleep 
disturbance predicts depression 1 year later, as ascertained by 
diagnostic interview, among community-dwelling older adults 
with prior depression.
These observations are consistent with meta-analytic findings 
that insomnia predicts depression,16 and extend understanding of 
the role of sleep disturbance in the natural course and outcome 
of depression.25,26 Our results suggest that depression history 
and the persistence of sleep disturbance might contribute to the 
heterogeneity of prior results. First, a prospective association 
between sleep disturbance and depression appears to be specific 
to those with a history of depression. At year 2, no control 
participants had depression, even though one-third of this 
group reported sleep disturbance with a quarter of those having 
persistent sleep disturbance. Only two studies11,17 have evalu-
ated the role of depression history in subsequent depression in 
community-dwelling older adults, although many studies have 
used clinical samples with such a history.16,23 Further, none of 
the prior studies used a SCID interview, for example, to obtain 
a history of lifetime Axis I disorders. Hence, it is possible that 
prior findings linking sleep disturbance with depression risk 
were due to the inclusion of those with a depression history, 
who were not identified as such. Nevertheless Jaussent et al. 
found that elderly individuals with persistent insomnia and 
without a depression history were at risk for depressive symp-
toms over 6 years, although a comparative evaluation of risk 
between those with and without a depression history was not 
reported.11 Second, the persistence of sleep disturbance, but not 
its severity, is strongly associated with depression risk. Whereas 
prior studies included participants who showed varying dura-
tions of insomnia, from several weeks to longer than 1 year,16 
sleep disturbance was typically assessed at a single time point. 
Moreover, sleep disturbance and depression have often been 
concurrently assessed without consideration of their temporal 
overlap.24-26 Third, there appears to be a cumulative effect of 
sleep disturbance on depression risk.
Understanding the role of nonmodifiable (e.g., depression 
history) and modifiable (e.g., persistent sleep disturbance) risk 
factors for depression has advanced a compelling rationale for 
developing targeted interventions for the prevention of depression 
in older adults. Whereas a universal prevention approach may be 
optimal for reducing population-wide incidence of depression, 
such an approach would be an enormous enterprise, with an esti-
mated 35,000 participants required to demonstrate a decrease in 
depression incidence.36 However, by selectively targeting older 
adults with a depression history and persistent sleep disturbance, 
the number needed to treat (NNT) is dramatically reduced.17 For 
example, assuming the use of a behavioral intervention (e.g., 
cognitive behavioral therapy for insomnia) with a 50% treatment 
efficacy,37 the NNT is reduced to less than 10. Considering the 
various sleep interventions available, it should be noted that use 
of sedative-hypnotic medications was not protective in the current 
study, although our determination of prescription and over-the-
counter sleep medication use relied on self-report, and we did 
not assess whether use frequency or dosage met clinical treat-
ment adherence guidelines. Behavioral interventions have been 
found to be effective in the treatment of insomnia in older adults,37 
without the risk profile of sedative-hypnotic medications.38
We could not examine the relationship between persistent 
sleep disturbance and subsequent depression in the control 
group because none of the participants developed depression 
during year 2. The relatively short duration of follow-up may 
have affected these results.39-42 Also, the incidence of depres-
sion in the elderly is variable, ranging from 2 to 22.6 per 
1000 person-years, and it is those older adults with a history 
of depression who are more likely to experience depressive 
episodes. Finally, late-onset depression is often related to 
medical illness, including cardiovascular disease and neurolog-
ical condition, but our study sample had low levels of medical 
morbidity and was primarily Euro-American. That is, persistent 
sleep disturbance may be less associated with depression risk in 
elderly populations who are neither mentally nor physically ill.
Several other limitations of our study should be considered 
when interpreting the results. First, these observations do not 
necessarily generalize to community-dwelling older adults who 
have not had prior depression. Second, this study focuses only 
on unipolar, not bipolar, depression. Third, only 11 participants 
from intermittent sleep disturbance group had depression at 
year 2, which may have resulted in low power to detect associa-
tions between sleep disturbance and depression prevalence or 
recurrence, despite a high hazard ratio (5.61). However, another 
study also demonstrated that single-episode insomnia is not 
associated with an increase in depressive symptoms at follow- 
up.26 Fourth, our assessment of sleep quality relied on self-
report. Whereas actigraphy or polysomnography is arguably the 
objective standard to assess sleep disturbance, the diagnosis of 
insomnia relies on subjective reports of sleep disturbance and 
daytime impairment similar to the PSQI.
Despite these methodological limitations, several major 
strengths distinguish this current study from previous efforts. 
First, the separate evaluation of depression from sleep distur-
bance, over a 1-year interval, provides evidence for a contri-
bution of persistent sleep disturbance to depression risk; in 
contrast, concurrent evaluation of sleep disturbance and depres-
sion does not define a prospective risk relationship.24,25 Second, 
depression was assessed with the SCID, which is known as the 
gold standard for the diagnosis of depression and is reliable in 
assessing depression history.
In conclusion, persistent sleep disturbance during a year-
long period is associated with depression the following year. 
Persistent sleep disturbance is also prospectively associated 
with depression recurrence among individuals those who were 
not depressed 1 year earlier. These results provide evidence that 
the identification of older adults with current or prior depres-
sion, as well as persistent sleep disturbance, may optimize the 
efficacy of sleep related interventions to improve depression 
remission and/or prevent late-life depression. Finally, further 
studies are needed to identify the characteristics of previously 
depressed populations who develop persistent sleep distur-
bances for priority monitoring of depression recurrence.
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SUPPLEMENTAL MATERIAL
Figure S1—Time-varying changes in sleep disturbance (Pittsburgh Sleep Quality Index [PSQI] ≤ 5 vs. > 5) across baseline, 6 weeks, and year 1 in the control 
patients, those with prior depression, and those with current depression at baseline.
Table S1—Component scores of the Pittsburgh Sleep Quality Index at baseline in the three groups
Component
Prior 
depression
(n = 145)
Current 
depression
(n = 68)
Control
(n = 206)
Sleep quality, mean (SD) 0.86 (0.75) 1.34 (0.77) 0.49 (0.63)
Sleep latency, mean (SD) 0.84 (0.91) 1.33 (1.0) 0.51 (0.72)
Sleep duration, mean (SD) 0.44 (0.71) 0.87 (0.98) 0.37 (0.67)
Habitual sleep effi ciency, mean (SD) 0.71 (0.95) 1.01 (1.08) 0.35 (0.69)
Sleep disturbances, mean (SD) 1.4 (0.64) 1.67 (0.66) 1.15 (0.52)
Use of sleeping medication, mean (SD) 0.82 (1.21) 1.03 (1.36) 0.34 (0.79)
Daytime dysfunction, mean (SD) 0.74 (0.61) 1.48 (0.68) 0.42 (0.58)
SD, standard deviation.
